Posters
Onconephrology: Epidemiological Trends, Risk Stratification, and Clinical Outcomes
October 24, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
CKD Outcomes Among Patients Treated with Immune Checkpoint Inhibitors
National Incidence, Predictors, and Outcomes of AKI After Cardiac Implantable Electronic Device Placement in Patients with Active Malignancy
Early Clinically Significant Kidney Deterioration After Cancer Diagnosis and One-Year Mortality Across Major Cancer Types
Integrated Spatial and Single-Cell Transcriptomics of Human Kidney Biopsies Reveals Distinct Immune Architecture in Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis
Granulomatous Acute Interstitial Nephritis in Patients Receiving Immune Checkpoint Inhibitor Therapy: Clinical Outcomes and Tumor Necrosis Factor (TNF)-α Expression
Limited Accuracy of eGFR Compared with Iohexol-Measured GFR in Patients Receiving CDK4/6 Inhibitors
Variability in Proteinuria Screening During Vascular Endothelial Growth Factor/Tyrosine Kinase Inhibitor Therapy: Room for Improvement!
Contemporary Use of Anticancer Drugs Requiring Dose Modification for GFR in US Adults with CKD
GFR Decline During Anticancer Therapy Based on Multiple Filtration Markers: A Prospective Cohort Study
Effect of GFR Difference on the Overall Survival of Adult Patients Exposed to Anticancer Treatment
Electrolyte Disturbances in Patients with Cancer Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Rising Incidence-to-Mortality Gap in Renal Malignancies: A 22-Year Population-Based Study
Beyond Kidney Outcomes: Mental Health and Vulnerability in Onconephrology
Kidney Function Decline After Treatment for Metastatic Castration-Resistant Prostate Cancer
Long-Term Kidney Outcomes in Patients with Chronic Myeloid Leukemia (CML) Treated with Ponatinib: A Real-World Cohort Study
Safety and Efficacy of Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma and Kidney Impairment: An Analysis of the ALGONQUIN Trial
Large Single-Center Clinicopathologic Experience of Monotypic Membranous Nephropathy with Cryptic Drivers
Performance of a Score for Stratifying the Risk of Significant CKD and Predictors of GFR Decline in Patients with Renal Cell Carcinoma Undergoing Nephrectomy
International Survey of Practice Patterns Regarding Prevention of Cisplatin-Associated AKI
AKI After Bispecific T-Cell Engager Therapy in Patients with Hematologic Malignancies: A Multicenter Cohort Study
AKI After Chimeric Antigen Receptor-T Cell Therapy: Incidence, Clinical Course, and Kidney Outcomes
Neurotoxicity Is Associated with AKI After Chimeric Antigen Receptor-T Cell Therapy Independent of Cytokine Release Syndrome
Predictors of 28-Day Mortality in Critically Ill Patients with Cancer Requiring Hemodialysis for AKI
Immune Checkpoint Inhibitors in Patients with Cancer and CKD: A Systematic Review and Meta-Analysis
Kidney Biopsy in the Era of Immune Checkpoint Inhibitors: Safety, Diagnostic Heterogeneity, and the Case for a Biopsy-First Strategy
Effect of Immunosuppression Modulation on Clinical Outcomes in Kidney Transplant Recipients Receiving Immune Checkpoint Inhibitors
Does Kidney Replacement Therapy Improve Outcomes in Patients with Stage IV Metastatic Cancer? A 17-Year Retrospective Cohort Study
Long-Term Evolution of Kidney Function After Chimeric Antigen Receptor (CAR)-T Cell Therapy Infusion in Patients with Relapsed/Refractory Hematological Malignancies (R/RHM)
Data from a Novel Prospective Onconephrology Clinic Registry: Comparison of Initial Data from Two Tertiary Care Centers
AKI After Bispecific Antibody Therapy in Patients with Plasma Cell and Lymphoid Malignancies
Renal Scintigraphy in the Management of Kidney Dysfunction After Cystectomy and Urinary Diversion in Patients with Cancer: A Case Series
Effect of the Difference in eGFR Based on Creatinine and Cystatin C on the Overall Survival of Patients with Cancer
Immune Checkpoint Inhibitors and AKI in Patients with Cancer and COVID-19
Serious Adverse Events in Patients with Metastatic Renal Cell Carcinoma and ESKD Receiving Systemic Anticancer Therapy: A Real-World Study
Overall Survival with Sequential Systemic Anticancer Therapy and First-Line Response in Patients with Metastatic Renal Cell Carcinoma and ESKD: A Real-World Analysis
AKI After Hepatic Histotripsy: Insights from the FDA MAUDE Database
Incidence, Predictors, and Outcomes of Tumor Lysis Syndrome-Associated AKI Requiring Dialysis in Hospitalized Patients with Diffuse Large B-Cell Lymphoma
Magnolin Inhibits Renal Carcinoma Cell Metastasis by Targeting TGF-β1/SMAD/AP1-Mediated MMP-9 Expression
Antineoplastic Agents and Worsening Proteinuria: The Impact of Baseline Proteinuria
Protecting the Kidney Without Compromising Cancer Therapy: Integrin α3β1 Antibody Treatment for Chemotherapy-Induced Injury
Clinical Characteristics of Renal Cell Carcinoma in Patients on Dialysis: Associations with Dialysis Vintage, Acquired Cystic Kidney Disease, and Bilateral Tumors
Comparative Implementation Pathways for Measured GFR (mGFR) Adoption Across Nephrology and Oncology
Beyond Conventional Immunosuppression: The Emerging Role of Chimeric Antigen Receptor-T Cell Therapy for Refractory Lupus Nephritis
Putative Mechanisms of Hypophosphatemia Associated with Antineoplastic Agents
Analgesic Use and Stronger Analgesic Therapy Are Associated with Hyponatremia in Patients with Malignancy
Importance of the Onconephrology Outpatient Clinic in the Follow-Up and Clinical Outcomes of Patients with Cancer
Immune Checkpoint Inhibitor-Associated IgAN: Long-Term Kidney and Patient Outcomes from a Large Single-Center Cohort
Hyperthermic Intraperitoneal Chemotherapy Associated with Acute Interstitial Nephritis
Sex-Based Differences in Cisplatin-Induced Nephrotoxicity: Divergent Immunological and Pathological Responses
Vascular Endothelial Growth Factor Inhibitors May Not Need to Be Stopped After New-Onset Proteinuria in Patients with Cancer
What Drives Severity of Spontaneous Renal Hemorrhage? Clinical Predictors and Outcomes
Kidney Biopsy Enables Accurate Diagnosis of Antivascular Endothelial Growth Factor (VEGF)-Related Kidney Toxicity
Renal Manifestations in Patients Diagnosed with Waldenstrom Macroglobulinemia
Howling at the Wrong Wolf: Lymphomatous Renal Infiltration Behind the Face of Lupus Nephritis!
Severe Hyponatremia After Mirvetuximab Soravtansine Therapy: A Case of Suspected Drug-Associated Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
A Rare Case of Paraneoplastic Minimal Change Disease in Neuroendocrine Cancer
Immune Checkpoint Inhibitor-Associated Fulminant Myocarditis Successfully Treated with Plasma Exchange Combined with High-Dose Glucocorticoids: A Case Report
When the Cure Triggers the Crisis: Rapid-Onset, Life-Threatening Diabetic Ketoacidosis (DKA) as a Consequence of Immune Checkpoint Inhibition with Nivolumab
Urinary CD4+ EM CD38+ HLA DR+ T Cells Are a Potential Biomarker for Diagnosis of Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis